Body Handbook Catalogue Profile Ranking
Psychology BODY HANDBOOK
Psychology ยท ยง472
Premenstrual Dysphoric Disorder (PMDD)
For one in twenty menstruating women, the two weeks before a period turn into something close to a major depressive episode, then bleeding starts and it lifts. That is PMDD, a cyclical mood disorder, and about a third of those affected have attempted suicide. Here's what you didn't know you didn't know: the hormones are normal and the treatments are cheap. The real gate is a diagnosis most doctors never learned to make, and clearing it gets back the week you lose every month.
Condition Evidence Moderate Chapter Psychology

It is not unusual hormones. Women with PMDD have the same estrogen and progesterone as everyone else on a given cycle day 1; what differs is a heritable difference in how the brain reads the normal monthly swing 2. Shut off the cycle and symptoms vanish; add either hormone back and they return, but only in women who have PMDD 3. So "balancing your hormones" with progesterone loads the trigger and backfires.

The tell is the calendar. Symptoms hit in the luteal phase, the two weeks after ovulation, and clear by day four of your period. That pattern separates PMDD from bipolar II and borderline, which cycle too but ignore the calendar 4. First-line treatment is an SSRI, and the evidence is unusually clean: across 31 trials, response runs about 60 to 70% 5. The useful oddity is speed: SSRIs work in days here, not the six weeks they take for depression, so one luteal phase tells you if it helps.

The diagnosis comes before the prescription; that is the step everyone skips.

Adjuncts worth adding: PMDD-specific CBT, whose effect outlasts the course 9, aerobic exercise around 150 minutes a week 10, and calcium 1,200 mg/day 11.

The first treated luteal phase is the tell. On an effective SSRI, most responders feel that week as recognisably different within days, the mood floor no longer dropping 12. By the third cycle the week you used to brace for is a normal one, and the energy, focus, and sleep the bad weeks ate come back. This is management rather than cure: skip the pill and a bad luteal phase returns within a cycle, and PMDD ends for good only at menopause.

The fine print โ€” when to skip it, and what people get wrong

PMDD is not severe PMS. PMS is bloating and mild irritability; PMDD is clinical-grade mood disturbance that wrecks functioning, and sits among the depressive disorders 13. Evening primrose, B6, and magnesium have no evidence for its affective core.

These are prescription drugs; none is a self-help protocol. Drospirenone pills are off the table if you smoke over 35, have had a clot, or get migraine with aura. GnRH agonists cause a temporary menopause, so they need add-back hormones and time limits. SSRIs carry a black-box suicide warning in young adults, weighed against PMDD's own high suicide risk by a clinician.

Why it "didn't work": the diagnosis was never confirmed, and about 40% of the certain turn out to have a mood disorder that only worsens premenstrually 5. Or the trial ran under two cycles, or the SSRI or pill was the wrong one.

References
  1. 1Yonkers KA, O'Brien PM, Eriksson E (2008). Premenstrual syndrome. Lancet. link
  2. 2Dubey N, Hoffman JF, Schuebel K, Yuan Q, Martinez PE, Nieman LK, Rubinow DR, Schmidt PJ, Goldman D (2017). The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder. Molecular Psychiatry. link
  3. 3Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. New England Journal of Medicine. link
  4. 4Eisenlohr-Moul TA, Girdler SS, Schmalenberger KM, Dawson DN, Surana P, Johnson JL, Rubinow DR (2017). Toward the reliable diagnosis of DSM-5 premenstrual dysphoric disorder: the Carolina Premenstrual Assessment Scoring System (C-PASS). American Journal of Psychiatry. link
  5. 5Marjoribanks J, Brown J, O'Brien PM, Wyatt K (2013). Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews. link
  6. 6Endicott J, Nee J, Harrison W (2006). Daily Record of Severity of Problems (DRSP): reliability and validity. Archives of Women's Mental Health. link
  7. 7Lopez LM, Kaptein AA, Helmerhorst FM (2012). Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database of Systematic Reviews. link
  8. 8Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O'Brien PM (2004). The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis. BJOG: An International Journal of Obstetrics and Gynaecology. link
  9. 9Lustyk MK, Gerrish WG, Shaver S, Keys SL (2009). Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Archives of Women's Mental Health. link
  10. 10Daley A (2009). Exercise and premenstrual symptomatology: a comprehensive review. Journal of Women's Health. link
  11. 11Thys-Jacobs S, Starkey P, Bernstein D, Tian J (1998). Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. American Journal of Obstetrics and Gynecology. link
  12. 12Pearlstein T, Steiner M (2008). Premenstrual dysphoric disorder: burden of illness and treatment update. Journal of Psychiatry and Neuroscience. link
  13. 13Halbreich U, Borenstein J, Pearlstein T, Kahn LS (2003). The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology. link
ยท
472